Olaplex Holdings, Inc. (OLPX)
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
QuarterlyIQ Insights · OLPX
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Changes in Control of Registrant. As a result of the consummation of the Merger, a change in control of the Company occurred, and the Company became a wholly owned Subsidiary of Parent. The total equity value of the transaction was approximately $1.4 billion. The funds used by Parent to consummate the Merger and complete the related transactions came from cash on hand of Parent and its affiliates. The information set forth in the Introductory Note of this Current Report on Form 8-K and the di…
Director — John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White: Directors departed due to the Merger.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. In connection with the consummation of the Merger, the Company notified representatives of Nasdaq Stock Market LLC (“ Nasdaq ”) of the consummation of the Merger and requested that Nasdaq delist the Common Stock. As a result, shares of Common Stock ceased to trade on the Nasdaq Global Select Market prior to market open on July 7, 2026, and became eligible for delisting from Nasdaq and terminat…
Other Events. The Company previously disclosed that it intended to hold its 2026 Annual Meeting of Stockholders (the “ 2026 Annual Meeting ”) on July 9, 2026. In consideration of the closing of the Merger, the board of directors of the Company has canceled the 2026 Annual Meeting.
Material Modification to Rights of Security Holders. In connection with the consummation of the Merger, at the Effective Time, holders of shares of Common Stock, Company Options and Company RSU Awards ceased to have any rights in connection with their holding of such securities (other than their right to receive the consideration described in
Termination of a Material Definitive Agreement. In connection with the consummation of the Merger, on July 7, 2026, the Company repaid in full all outstanding indebtedness and terminated all commitments under that certain Credit Agreement, dated as of February 23, 2022, by and among Olaplex, Inc., as the borrower, Penelope Intermediate Corp., as holdings, Goldman Sachs Bank USA, as administrative agent for the lenders, as collateral agent for the secured parties, as an issuing bank and as the…
Completion of Acquisition or Disposition of Assets. Pursuant to the Merger Agreement, at the effective time of the Merger (the “ Effective Time ”), each share (a “ Share ” and collectively, the “ Shares ”) of common stock, par value $0.001 per share, of the Company (the “ Common Stock ”), issued and outstanding immediately prior to the Effective Time (other than Shares held by the Company as treasury stock or held directly by Parent or Merger Sub, or any direct or indirect wholly owned Subsid…
Other Events. On May 7, 2026, the United States District Court for the Central District of California granted preliminary approval of the settlement in the stockholder derivative action captioned In re Olaplex Holdings, Inc. Stockholder Derivative Litigation, Lead Case No. 2:23-cv-09712-SVW-SK (the “Settlement”). The Settlement resolves all claims that were or could have been asserted in the derivative litigation and the books and records demand made by stockholder Kajeel Patel pursuant to 8…
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Entry into a Material Definitive Agreement. Merger Agreement On March 26, 2026, Olaplex Holdings, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Henkel US Operations Corporation, a Delaware corporation (“ Parent ”), and Margot Acquisition Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“ Merger Sub ”), pursuant to which, subject to the satisfaction or waiver of…
Regulation FD Disclosure. On March 26, 2026, the Company issued a press release in connection with the transaction. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The information in this Item 7.01, including Exhibit 99.1 , is furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the fil…
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Entry into a Material Definitive Agreement. On August 20, 2025 (the “Closing Date”), Olaplex, Inc. (“Olaplex”), a Delaware corporation and wholly-owned subsidiary of Olaplex Holdings, Inc., entered into a Stock Purchase Agreement (the “Purchase Agreement”), among Olaplex, Purvala Bioscience, Inc., a Delaware corporation (“Purvala”), the stockholders and optionholders of Purvala (the “Former Holders”), including Lavinia Popescu, the Chief Science and Research Officer of Olaplex Holdings, Inc.,…
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Director — Jerome Griffith: Election of Jerome Griffith as a Class I director.
Director — Paula Zusi: Ms. Zusi's term ended with her resignation from the Board.
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Chief Accounting Officer — Stephen J. Bacica: Mr. Bacica resigned to pursue other interests and for personal reasons.
Director — Pamela Edwards: Election of Pamela Edwards as a Class II director and appointment to the Audit Committee.
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Director — Janet Gurwitch: Janet Gurwitch resigned as a member of the Board of Directors.
of this Current Report on Form 8-K, including the exhibit, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Senior Vice President, Accounting — Kristi Belhumeur: Ms. Belhumeur resigned to pursue another opportunity.
Chief Operating Officer and Chief Financial Officer — Catherine Dunleavy: Catherine Dunleavy was appointed as Chief Operating Officer and Chief Financial Officer, completing a leadership transition.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.